Riskpilot← Back to searchSign inGet full accessTT psykiatri konsult AB
ABActiveOrg 5592244338Brunsoppsvägen 36Hospital activities · NACE 8610Est. 20191 employees
Revenue 2024
SEK 1,2M
-32% vs 2023
EBITDA margin
51.1%
-50% vs 2023
Equity ratio
90.8%
Financial strength
Net profit 2024
SEK 464K
-50% vs 2023
| Revenue | SEK 1,2M | -32% |
| EBITDA | SEK 591K | -50% |
| Net profit | SEK 464K | -50% |
| Total assets | SEK 2,6M | +6% |
| Equity | SEK 2,3M | +17% |
| Employees | 1 | — |
Legal name
TT psykiatri konsult AB
Org number
5592244338
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
29 oktober 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk konsultation, utbildning, personalbemanning, handel med värdepapper samt äga och förvalta fastigheter och idka därmed förenlig verksamhet.
Address
Brunsoppsvägen 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 214 | 781 | 1 053 | 1 691 | 1 155 |
| Staff expenses | — | — | −49 | −66 | −85 |
| EBITDA | 833 | 411 | 658 | 1 176 | 591 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 833 | 411 | 658 | 1 176 | 591 |
| Net financials | — | — | −0 | 7 | −1 |
| Profit before tax | 832 | 411 | 658 | 1 183 | 590 |
| Tax | −178 | −85 | −137 | −248 | −125 |
| Net profit | 654 | 326 | 521 | 935 | 464 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 980 | 1 168 | 1 469 | 2 422 | 2 560 |
| Equity | 704 | 781 | 1 301 | 1 981 | 2 325 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 276 | 387 | 168 | 441 | 235 |
| Total debt | 276 | 387 | 168 | 441 | 235 |
EBITDA margin
51.1%
This company
15.8%
Market median
+223% vs market
20202024
Equity ratio
90.8%
This company
38.2%
Market median
+138% vs market
20202024
Return on equity
20.0%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
40.2%
This company
8.1%
Market median
+396% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TT psykiatri konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Athanasios Tournavitis | Chief Executive Officer | 0 companies |
| Anna Maria Margareta Samuelsson | Deputy Board Member | 0 companies |